Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

Nemtabrutinib, Bortezomib, and Rituximab for WM

NCT07464210

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Not Yet Recruiting

NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy

NCT07462299

Conditions: Childhood Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The Children's Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

NCT07458659

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: King Chulalongkorn Memorial Hospital Bangkok, Pathumwan, Thailand

View Trial Details

Not Yet Recruiting

Are Clinical Outcomes Unchanged by ALL Fixation at 0° or 30° of Knee Flexion in Combined ACL-ALL Reconstruction? Despite Numerous Technical Descriptions of Anterolateral Procedures, There is Limited Knowledge Regarding the Effect of Knee Flexion Angle During Graft Fixation.

NCT07451743

Conditions: Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia

NCT07223190

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors

NCT07297160

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hematologic Diseases, +23 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details

Not Yet Recruiting

CD34+ Transplants for Leukemia and Lymphoma

NCT05565105

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Baptist Health South Florida/Miami Cancer Institute Miami, Florida, United States

View Trial Details

Not Yet Recruiting

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

NCT07029776

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Not Yet Recruiting

Treatment for Ph-negative ALL for Adults up to 65 Years

NCT07443592

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Hospital de A Coruña A Coruña, Spain

Hospital Universitario de Araba Alava, Spain

Hospital General Universitario de Albacete Albacete, Spain

Hospital General Universitario Dr. Balmis Alicante, Spain

View all 95 locations

View Trial Details

Not Yet Recruiting

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +77 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Birmingham Children's Hospital Birmingham, United Kingdom

Bristol Royal Hospital for Children Bristol, United Kingdom

View all 27 locations

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions